VKH
NTRP

Virtu KCG Holdings’s Neurotrope, Inc. Common NTRP Stock Holding History

Virtu KCG Holdings’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$227K Buy
+24,236
New +$259K 0.01% 2027

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Virtu KCG Holdings's NTRP Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Neurotrope, Inc. Common (NTRP) in Q2 2017: 24,236 shares worth $227K. The stake represents 0.01% of the portfolio and ranks #2027 among its holdings.

27 funds tracked by Wall St. Rank hold NTRP as of Q2 2017.

  • Virtu KCG Holdings held 24,236 shares of Neurotrope, Inc. Common worth $227K as of Q2 2017.
  • Neurotrope, Inc. Common was a new Virtu KCG Holdings position in Q2 2017.
  • Neurotrope, Inc. Common made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2027 holding.
  • 27 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.